You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 4, March 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Infective Endocarditis and Mitral Prolapse A Comparison With Other Types of Endocarditis

Charles M. Nolan, MD; James J. Kane, MD; William A. Grunow, MD

Arch Intern Med. 1981;141(4):447-450.


Abstract

• We compared clinical features, response to therapy, and outcome of infective endocarditis in ten patients with mitral valve prolapse and 23 patients with endocarditis involving other types of left-sided valvular lesions. Signs of endocarditis were more subtle in patients with mitral valve prolapse, and antimicrobial therapy was instituted later in those patients. Nevertheless, nine of ten patients with mitral valve prolapse and endocarditis responded optimally to antimicrobials; only five of 23 patients with other types of endocarditis responded similarly. Four patients with mitral valve prolapse experienced increasing valvular dysfunction during the year after treatment of endocarditis; one died. We conclude that endocarditis in patients with mitral valve prolapse is more responsive to antimicrobial therapy even though recognition of the infection often is delayed. However, mitral valve prolapse endocarditis is not a benign infection, because progressive valvular dysfunction is a frequent sequel.

(Arch Intern Med 1981;141:447-450)



Author Affiliations

From the Departments of Medicine (Drs Nolan and Kane) and Pathology (Dr Grunow), University of Arkansas College of Medicine, and Veterans Administration Hospital (Dr Kane), Little Rock, Ark. Dr Nolan is now with the Department of Public Health, Seattle.


Footnotes

Accepted for publication March 3, 1980.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mitral Valve Prolapse: Causes, Clinical Manifestations, and Management
Devereux et al.
ANN INTERN MED 1989;111:305-317.
ABSTRACT  

35th Annual Meeting -- American College of Angiology Orlando, Florida -- October, 1988 Symposium Proceedings: Neurologic Aspects of Mitral Valve Prolapse
Heck
ANGIOLOGY 1989;40:743-751.
ABSTRACT  

Coagulase-Negative Staphylococcal Endocarditis: Occurrence in Patients With Mitral Valve Prolapse
Baddour et al.
Arch Intern Med 1986;146:119-121.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.